Oxford University’s coronavirus vaccine opens for clinical trial on humans

ChAdOx1 nCoV-19, the COVID-19 vaccine developed by Oxford, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein.

from The Hindu - Science https://ift.tt/2WLGD2N

Comments

Popular posts from this blog